Resmetirom was approved by the United States Food and Drug Administration(FDA) for the treatment of nonalcoholic steatohepatitis (NASH) on March 14,2024
This is the first FDA-approved treatment for NASH and marks an important milestone in the field.
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: